Santa Cruz Biotechnology delivers a wide array of REXO1 monoclonal antibodies for research focused on understanding REXO1 protein functions. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). REXO1, also known as RNA exonuclease 1, plays a critical role in RNA metabolism, particularly in the degradation of RNA molecules and the regulation of gene expression. REXO1 functions are essential for maintaining cellular homeostasis and responding to stress conditions, making it a significant target for studies related to cellular processes and disease mechanisms. Understanding REXO1 dynamics can provide insights into various biological pathways and potential therapeutic targets. Researchers can explore REXO1's involvement in RNA processing pathways and its impact on gene regulation. REXO1 studies have revealed important connections to cellular stress responses and potential implications in disease development. REXO1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of RNA metabolism and cellular regulation mechanisms.